Injection Site Selection The most common and effective injection sites for AOD-9604 include: Abdominal Region (Preferred): Inject into fatty tissue at least 2 inches away from the navel, avoiding the midline
If any of these occur, consult your healthcare provider immediately
If you do everything quickly and if your child does awaken, you will be there to comfort him/her immediately and your child will not know that an injection has occurred
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
Why Metabolic Safety Matters Full-length human growth hormone therapy carries well-documented metabolic risks including IGF-1 elevation, impaired glucose tolerance, and increased diabetes risk
